Search

Your search keyword '"Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436"' showing total 3 results
Start Over Descriptor "Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436"
3 results on '"Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436"'

1. Agouron Announces Expanded Access Program For HIV Protease Inhibitor VIRACEPT(TM)

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Business, News, opinion and commentary
Abstract

LA JOLLA, Calif., Sept. 16 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. (Nasdaq-NNM: AGPH) today announced the availability of VIRACEPT(TM) (nelfinavir mesylate), an HIV protease inhibitor, through an expanded access program for [...]

Published
1996

2. AIDS and Agouron

Author

Gianturco, Michael

Subjects
Pharmaceutical industry -- Product introduction, Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436
Published
1998

3. Agouron girds to join AIDS-drug battle: biotech firm's Viracept is a pricey late entry

Author

Rundle, Rhonda L.

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, AIDS (Disease) -- Drug therapy, Banking, finance and accounting industries, Business, Business, international, Viracept (Medication) -- Product introduction
Published
1997

Catalog

Books, media, physical & digital resources
See catalog results